Differential protein expression of hippocampal cells associated with heavy metals (Pb, As, and MeHg) neurotoxicity::Deepening into the molecular mechanism of neurodegenerative diseases by Karri, Venkatanaidu et al.
 
 
 
Differential protein expression of hippocampal cells
associated with heavy metals (Pb, As, and MeHg)
neurotoxicity:
Citation for published version (APA):
Karri, V., Ramos, D., Bauza Martinez, J., Odena, A., Oliveira, E., Coort, S. L., Evelo, C. T., Mariman, E. C.
M., Schuhmacher, M., & Kumar, V. (2018). Differential protein expression of hippocampal cells associated
with heavy metals (Pb, As, and MeHg) neurotoxicity: Deepening into the molecular mechanism of
neurodegenerative diseases. Journal of Proteomics, 187, 106-125.
https://doi.org/10.1016/j.jprot.2018.06.020
Document status and date:
Published: 15/09/2018
DOI:
10.1016/j.jprot.2018.06.020
Document Version:
Publisher's PDF, also known as Version of record
Document license:
Taverne
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 09 Jan. 2021
Contents lists available at ScienceDirect
Journal of Proteomics
journal homepage: www.elsevier.com/locate/jprot
Differential protein expression of hippocampal cells associated with heavy
metals (Pb, As, and MeHg) neurotoxicity: Deepening into the molecular
mechanism of neurodegenerative diseases
Venkatanaidu Karria, David Ramosc, Julia Bauzá Martinezc, Antonia Odenac, Eliandre Oliveirab,
Susan L. Coortd, Chris T. Evelod, Edwin C.M. Marimane, Marta Schuhmachera, Vikas Kumara,f,⁎
a Environmental Engineering Laboratory, Departament d'Enginyeria Quimica, Universitat Rovira i Virgili, Av. Països Catalans 26, 43007 Tarragona, Spain
bUnidad de Toxicologia, Parc Científic de Barcelona, C/Baldiri Reixac, 10-12, 08028 Barcelona, Spain
c Plataforma de Proteòmica, Parc Científic de Barcelona, C/Baldiri Reixac, 10-12, 08028 Barcelona, Spain
d Department of Bioinformatics, BiGCaT, NUTRIM, Maastricht University, 6229, ER, Maastricht, the Netherlands
e Department of Human Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Centre, Maastricht, the Netherlands
f IISPV, Hospital Universitari Sant Joan de Reus, Universitat Rovira I Virgili, Reus, Spain
A R T I C L E I N F O
Keywords:
Metal exposure
Proteomics
Pathway visualization
Neurodegenerative diseases
A B S T R A C T
Chronic exposure to heavy metals such as Pb, As, and MeHg can be associated with an increased risk of de-
veloping neurodegenerative diseases. Our in vitro bioassays results showed the potency of heavy metals in the
order of Pb < As < MeHg on hippocampal cells. The main objective of this study was combining in vitro label
free proteomics and systems biology approach for elucidating patterns of biological response, discovering un-
derlying mechanisms of Pb, As, and MeHg toxicity in hippocampal cells. The omics data was refined by using
different filters and normalization and multilevel analysis tools were employed to explore the data visualization.
The functional and pathway visualization was performed by using Gene ontology and PathVisio tools. Using
these all integrated approaches, we identified significant proteins across treatments within the mitochondrial
dysfunction, oxidative stress, ubiquitin proteome dysfunction, and mRNA splicing related to neurodegenerative
diseases. The systems biology analysis revealed significant alterations in proteins implicated in Parkinson's
disease (PD) and Alzheimer's disease (AD). The current proteomics analysis of three metals support the insight
into the proteins involved in neurodegeneration and the altered proteins can be useful for metal-specific bio-
markers of exposure and its adverse effects.
Significance: The proteomics techniques have been claimed to be more sensitive than the conventional tox-
icological assays, facilitating the measurement of responses to heavy metals (Pb, As, and MeHg) exposure before
obvious harm has occurred demonstrating their predictive value. Also, proteomics allows for the comparison of
responses between Pb, As, and MeHg metals, permitting the evaluation of potency differences hippocampal cells
of the brain. Hereby, the molecular information provided by pathway and gene functional analysis can be used to
develop a more thorough understanding of each metal mechanism at the protein level for different neurological
adverse outcomes (e.g. Parkinson's disease, Alzheimer's diseases). Efforts are put into developing proteomics
based toxicity testing methods using in vitro models for improving human risk assessment. Some of the key
proteins identified can also potentially be used as biomarkers in epidemiologic studies. These heavy metal re-
sponse patterns shed new light on the mechanisms of mRNA splicing, ubiquitin pathway role in neurodegen-
eration, and can be useful for the development of molecular biomarkers of heavy metals exposure.
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1. Introduction
Many environmental pollutants have been associated with human
diseases [1]. Among various pollutants, heavy metals contribute to a
great proportion of air, soil and water pollution and cause major health
problems to human beings [2–4]. An increased worldwide in-
dustrialisation [5] has led to higher levels of pollution by potent neu-
rotoxins such as lead (Pb), arsenic (As), and methyl mercury (MeHg)
[6]. Both environmental and occupational exposures to any of the three
metals are of significant toxicological concern [7, 8]. Their multiple
industrial, domestic, agricultural, medical, and technological applica-
tions have led to their wide spreading in the environment [9, 10].
Heavy metal exposure can occur through contaminated air, food, water,
and/or hazardous occupations [11–14]. The toxicity of heavy metals
depends on several factors including dosage, route of exposure and
chemical species, as well as on the age, gender, genetics, and nutritional
status of exposed individuals [15–17]. Human exposure to three heavy
metals (Pb, As, and MeHg) can disrupt brain function [18, 19], and
increase the risk of diseases such as Alzheimer's disease (AD) and Par-
kinson's disease (PD) [20–22].
These three heavy metals (Pb, As, and MeHg) are well known potent
toxicants, and humans are exposed to each one of them via different
routes [23, 24]. Firstly, the main routes of exposure for Pb are in-
halation and ingestion [25, 26]. Inhalation exposure to Pb is a much
more efficient route of absorption than ingestion [27, 28]. Pb metal is
relatively common in the environment, and its toxicity impacts the
children health [29]. Pb exposure in the workplace is responsible for a
wide range of adverse effects, mainly on the brain [30]. Secondly,
humans are exposed to various forms of As mainly via oral consumption
of contaminated water, food or drugs [31, 32]. As metal can also enter
the body via inhalation, which is particularly important for certain
types of occupational exposure [33–35]. Also As metal is rapidly ab-
sorbed, distributed and stored in different body organs such as liver,
kidney, and lung. Moreover, it can easily cross the blood brain barrier
(BBB) and accumulate in the brain [36, 37]. Reported studies state that
As metal has been directly linked to neurodegenerative diseases [38].
These findings raised concern over As induced neurotoxicity in humans
[39–41]. However, the underlying molecular mechanisms not clear.
Finally, MeHg contamination is possible through consumption of fish
and other seafood [42, 43]. In humans, MeHg accumulates in kidneys
and neurological tissues [44]. It is well known that ingested MeHg can
interact with proteins due to its strong affinity to sulphur (-SH) con-
taining functional groups, and cause organ dysfunction in the central
nervous system [45, 46].
In the past few years, many studies have been conducted to un-
derstand the mechanisms underlying Pb, As and MeHg toxicity on the
hippocampus region of the brain [47–49] Exposure to Pb and MeHg
have significant effects on the human brain [50, 51]. Many reported
evidence linked As exposure with developmental neurotoxicity [52].
Recently, Karri et al. reported that Pb, As, and MeHg exposure induce
damage to the hippocampus region of the brain [53]. However, the risk
level depends on exposure intensity and metal nature in the brain [39,
54]. Basha et al. observed that developmental exposure to Pb exhibits
latent effects [20], through the epigenetic interaction of Pb with amy-
loid precursor protein (APP) gene causing neurodegeneration at an
older age. As can disrupt the cognitive function of the brain in children
[52]. MeHg directly disrupts the mitochondrial function by generating
an uncontrolled release of Ca+2 [55], resulting in the dysregulation of
the mitochondrial electron transport chain (ETC) [56] and causes the
cell death. MeHg effect on mitochondria could be a potential cause of
neurodegenerative diseases [57].
Most of the reported studies focused on the effects of metals on the
brain in a generalized manner [46, 52, 58]. In the past few years,
substantial improvements in toxicogenomics knowledge have led to an
increase in the application of proteomics and systems biology knowl-
edge to answer these mechanistic biological questions [59, 60]. To
assess the biological effects of heavy metals, we are conducting studies
engaging a systems toxicology approach that combines evaluation of
classical toxicological endpoints with extensive molecular measure-
ments and pathway analysis approaches [61–64]. The main goal of this
project was taking advantage of high throughput proteomic technolo-
gies and systems biology tools for assessing the neurotoxicity me-
chanism of Pb, As, and MeHg on the hippocampal cells. We choose the
mouse hippocampal HT-22 cell line due to the known sensitivity of
chronic Pb, As, and MeHg exposure and relevant to the disease [65].
Here, a label-free quantitative proteomics approach [66] was used to
detect the effects of Pb, As, and MeHg exposure at the protein level by
using a non-cytotoxic dose (IC10) of each metal to avoid secondary
cytotoxic responses. The differential protein expression patterns in-
volved in the heavy metal toxic response were quantified to deeply
reveal the integrative molecular network of protein response to heavy
metal stress. The proteomics data were integrated with a systems
biology approach [67], in which the analysis tools PathVisio, GO-elite,
and Cytoscape were used to provide a more global view of the mole-
cular] changes elicited by heavy metals in hippocampal cells [68, 69].
2. Materials and methods
2.1. Chemicals
Lead chloride (PbCl2 [CAS no: 7758-95-4]), Sodium metaarsenite
(NaAsO2 [CAS no: 7784-46-5]), Methyl mercury chloride (MeHgCl2
[CAS no: 115-09-3]), Dimethyl sulphoxide (DMSO [D5879]), 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT
[M5655]), trypsin (TrypLE [Gibco: 12604013]), and proteomics re-
agents: Urea (GE HealthCare, Life Sciences, CAS Number: 57-13-6),
Sodium Dodecyl Sulphate (SDS) (Merck, CAS Number: 151-21-3),
Ammonium Hydroxide (Fluka, CAS Number: 1066-33-7), Dithiothreitol
(GE HealthCare, Life Sciences, CAS Number: 3483-12-3),
Iodoacetamide (GE HealthCare, Life Sciences, CAS Number: 144-48-9),
Formic Acid (Merck, CAS Number: 64-18-6), Acetonitrile (HPLC grade)
(Fisher Chemical, CAS Number: 75-05-8), and Water (HPLC grade)
(Fisher Chemical, CAS Number: 7732-18-5) are analytical grade and
purchased from Sigma-Aldrich Química, S.L-Madrid (Spain).
2.2. Cell line and reagents
The HT-22 cells have been used as a hippocampal neuronal cell
model in numerous studies [70]. The HT-22 cells were a generous gift
from Dr. David Schubert (The Salk Institute, La Jolla, CA). HT-22 cells
were maintained in Dulbecco's modified eagle's medium (DMEM
[D6429]) containing 10% fetal bovine serum (FBS Gibco [10500-064]),
100 U/mL penicillin, and 100 μg/mL streptomycin (Pan-Biotech- Ger-
many) in a humidified incubator with 5% CO2 in air at 37 °C. For all the
experiments cells were grown at 70–80% confluence. The cells were
cultured in 75 cm2 cell culture flasks. For experimental purpose, cells
were plated at 0.56×106 cells/mL and grown for 24 h (hrs.) before the
metal treatment. Duplicates wells of cells were treated with 10 exposure
levels of Pb, As, and MeHg ranging from 10 to 100 μM, 0.4 to 4.2 μM,
and 0.6 to 12 μM, respectively; due to the 8 days exposure-period,
medium containing the given concentration was refreshed at 2 days
interval in order to maintain the metal exposure along time. Metal stock
solutions 100× was prepared in deionized distilled water (for poorly
soluble PbCl2 < 0.5% DMSO was added) and sterilized by filtration
through 0.2 μm and different concentrations of a working solution for
each individual metal were prepared by prior dilution of the stock so-
lution in phosphate buffered saline (pH=7.4) and then applying 10%
working solution on DMEM culture medium.
2.3. Cytotoxicity
The MTT assay was carried out using a modification of the method
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of Mossman [71]. The HT-22 cells were seeded in 96-well plates. After
24 h, when the cells had reached a confluence of 70–80%, they were
exposed for 8 days to various concentrations of Pb, As, and MeHg. After
the incubation period, the medium was aspirated and MTT working
solution of 0.5mg/mL was added to each well. The absorbance of the
solubilized reduced MTT was then measured in a microtiter plate
spectrophotometer reader at a wavelength of 570 nm. The measured
optical density (OD) values were converted to percent of cell viability
(%) with respect to control. The cell viability results were used for
calculating the sub-lethal dose (IC10) of each metal for apoptosis and
proteomics studies.
2.4. Analysis of apoptosis by annexin V-FITC/propidium iodide (PI)
To evaluate the translocation of phosphatidylserine (PS) from inner
leaflets to outer leaflets of the plasma membrane, annexin V-FITC
apoptosis detection kit (BD Pharmingen, Poland) was utilized. In this
kit, annexin V and propidium iodide (PI) were used to distinguish the
apoptotic and necrotic cells from the viable cells. According to the
manufacture's protocol, the exponentially proliferating cells were ex-
posed to the IC10 to IC30 of heavy metals in culture plate at a density of
0.56×106/mL during 8 days; control cells were made without che-
mical. Cells were harvested by trypsinization, washed twice with ice
cold PBS (pH=7.4). Thereafter, cells were centrifuged at 1200 rpm for
5min at 4 °C, resuspended in 1mL 1× binding buffer and then 100 μL
of the solution was transferred to a 5mL culture tube, and 5 μL of both
annexin-V and PI was added to the samples. After staining, cells were
incubated for 15min in the dark place at room temperature. Finally,
cells were re-washed with 400 μL 1× binding buffer and analyzed by
flow cytometry (Beckman coulter, Germany). Three independent ex-
periments were performed.
2.5. Protein extraction and digestion
For the proteomics study, the exponentially proliferating HT-22
cells were exposed to the selected sub-lethal dose (IC10) of each heavy
metal at a density of 0.025×106/mL during 8 days; control cells were
made without chemical exposure. Pb, As, and MeHg treatment (and
control culture) protein was extracted from HT-22 cells with 200 μL
lysis buffer (8M urea, 0.1% SDS, 50mM ammonium bicarbonate
[ABC]) and quantified using the Micro BCA™ Protein Assay Kit (Thermo
Scientific). 30 μg of protein from each sample was digested in a filter
assisted sample preparation (FASP) approach. The volume corre-
sponding to 30 μg of protein was adjusted to 270 μL with 8M Urea/
50mM ABC. The reduction was done with 20mM dithiothreitol (DTT)
treatment for 1 h 30min at 32 °C. Samples were then alkylated using
30mM of iodoacetamide (IAA) and incubated in the dark for 30min at
room temperature. Afterwards, samples were loaded in 10 kDa filters
(Amicon) and centrifuged for 30min, 12,000 g at room temperature
followed by two washes with 300 μL 1M urea/50mM ABC by cen-
trifugation (30min, 12,000 g, room temperature) in order to remove
interferents and establish optimal pH (7.5–8.5) and urea concentration
for proteins to be denatured. The filter remaining material was re-
suspended in 400 μL 1M urea/50mM ABC. Digestion was done in two
steps: an initial digestion with 1:30 (w/w) porcine trypsin 0.25 μg/μL
(Sequence grade modified trypsin, Promega) for 3 h at 32 °C followed
by a digestion with 1:50 (w/w) trypsin 0.25 μg/μL for 16 h at 32 °C.
Peptides were eluted by centrifugation (12,000 g for 15min at room
temperature) and the filters were cleaned with 200 μL 50mM ABC by
centrifugation at 12,000 g for 15min at room temperature. Samples
were prepared for chromatographic analysis. Briefly, peptides re-
suspended in 100 μL of 1% formic acid (FA) were charged in the tip
columns (previously washed with 70% acetonitrile [ACN] in 0.1% FA
and equilibrated with 0.1% FA) by centrifugation (300×g for 1min
30 s). Columns were washed twice with 100 μL 0.1% FA by cen-
trifugation (300 g for 1min) and then peptides were eluted in
2×100 μL of 70% ACN / 0.1% FA by centrifugation (300 g for 1min).
The peptides were dried in speed vacuum (Eppendorf) and stored at
20 °C until LC-MS analysis.
2.6. LC-MS/MS analysis
The peptide mixtures were resuspended (1% FA, 2% ACN) and the
volume corresponding to 500 ng of protein was analyzed by an LTQ-
Orbitrap velos mass spectrometer (Thermo Fisher Scientific). Peptide
mixtures were injected into the capillary column (75 μm×25 cm) in
full loop mode and separated by a 5 μm C18 column using a nano-ac-
quity liquid chromatography system (Waters). Peptides were eluted
with a linear gradient of 1–35% buffer B (0.1% FA, 100% ACN) for
150min, followed by 35–45% buffer A for 20min (0.1% A). The mass
spectrometer was operated in positive ion mode (source voltage
2000 V) and data-dependent manner. The full MS scans were performed
in the Orbitrap at the range of 300–1700m/z at a resolution of 60,000.
For MS/MS scans, the 15 most abundant ions with multiple charge
states were selected for collision induced dissociation (CID) fragmen-
tation following one MS full scan.
2.7. Label-free quantitative (LFQ) data analysis using Progenesis QI
software
Proteomics quantitative data analysis was done by using Progenesis
QI data analysis software v4 (Non-Linear Dynamics, Waters, U.S.). Ion
feature matching was achieved by aligning consistent ion m/z and re-
tention times. Peptide abundances were calculated as the area under
the MS peak for every matched ion feature. Progenesis label free
quantification (LFQ) was done using non-conflicting unique peptides
and protein grouping, and the software normalization algorithm was
applied to all proteins. Mascot search results were filtered based on
peptide ion score≥ 40 and contaminants were removed and abun-
dances were normalized to all proteins. A total of 428,801 spectra were
obtained from the LFQ LC–MS/MS proteomic analysis of samples in-
cluding a control and test samples. After data filtering to eliminate low-
scoring spectra 27,088 peptides were retained and used for protein
identification. Total 3140 proteins were quantified from 27,088 peptide
ions. Only the proteins quantified with minimal 2 peptides were in-
cluded in the further statistical analysis.
2.8. Protein identification
Proteins identification was done using Mascot search engine (v.
2.3.01). All MS/MS spectra passing an arbitrary cut-off in the
Progenesis software were included in the list used to perform the search
against SwissProt Mouse database using the Mascot search program
(Matrix Science, London, UK, www.matrixscience.com). The following
criteria were applied: (1). trypsin as an enzyme; (2). allowed two
missed cleavages; (3). variable modifications, acetyl (N-terminus, pro-
tein) and oxidation (M); Carbamidomethyl (C) fixed modification and
(4). Peptide tolerance,± 10 ppm (MS); MS/MS tolerance,± 0.6 Da.
2.9. Statistical analysis
Label free quantitative data was submitted to t-test method
(p≤ .05) using Microsoft excels in order to find out significant differ-
ences among the treatments and control. Data were further curated
applying the following filters: minimum 1.2-fold change and p-
value < .05. Meaboanalyst 3.0 (http://www.metaboanalyst.ca) pro-
gramme was used for presenting the unsupervised data in the principal
component analysis (PCA), volcano plot, and hierarchical clustering
analysis.
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2.10. Systems biology analysis
In our systems biology analysis three main steps were included for
the quantitative functional interpretation of proteomics data. The first
step was aimed to identify the statistically significant proteins by using
the t-test method. The next step was to identify significantly altered
functional Gene Ontology (GO) categories using GO analysis. The al-
tered GO terms and the differentially expressed proteins in these GO
terms were visualized in a network to identify the links between the
terms. In the final step, the changes in protein expression were visua-
lized in selected pathways related to neurodegenerative diseases.
2.10.1. Functional interpretation of significantly altered genes using GO
analysis
GO-Elite (http://www.genmapp.org/go_elite/), a flexible and pow-
erful tool for GO functional analysis [72] was used to find altered
biological processes, molecular functions, and cellular components
based on changes in proteins expression. GO-Elite performs an over-
representation analysis (ORA) on any structured ontology annotations,
or biological identifiers (e.g. gene, protein or metabolite) [73]. The
program utilizes the structured nature of biological ontologies to report
a minimal set of non-overlapping terms called as pruned terms. Pruning
is the process of intelligently examining the hierarchical structure of
ontology, such as GO, and comparing the ORA scores of enriched terms
based on their relationships to each other. Highly related terms high-
lighted by ORA are considered to be redundant with each other. Hence,
pruning is used to select the highest scoring term among a set of related
terms, while retaining any distinct related terms. GO-Elite ranks each
analyzed pruned GO term according to a Z-score along with a p-value
[74]. Significantly altered categories were identified based on the p
value < .05, Z-score > 1.96, and a minimum of 3 proteins changed
within each specific GO term. The results were visualized as networks
linking the GO terms and differentially expressed proteins in the GO
terms using the network analysis tool Cytoscape [75]. In addition, on
the GO-protein network in Cytoscape, the log2 fold change (log2FC)
between each metal exposure group and control were visualized.
2.10.2. Pathway visualization
PathVisio [76] is a commonly used pathway editor, visualization,
and analysis software for omics based experiments. First, the required
curated Mus musculus pathway collection was obtained from Wiki-
pathways (http://www.wikipathways.org) [77]. Pathway analysis was
performed in PathVisio version 3.2.4 (http://www.pathvisio.org) to
interpret and visualize the molecular changes on a pathway level. In the
present study, we visualized the changes in proteins after metal ex-
posure in biological pathways relevant to neurodegeneration processes
in which a minimum of 3 proteins was changed. The log2FC and p-value
were shown on pathways using the visualization module in Path Visio.
A flow chart of experimental label free proteomics and systems biology
is shown in the Supplementary file 1 (Fig. 1).
3. Results and discussion
To characterize the proteomics changes of Pb, As, and MeHg in-
dividually on mouse hippocampal HT-22 cells during 8 days of ex-
posure, firstly we performed cell viability studies by using the MTT
assay. The cell confluence (80–85%) was stable until 8 days exposure;
consequently, we considered the 8 days exposure as chronic for further
mechanistic studies. As expected, all three metals showed concentration
and time-dependent cytotoxic effect. Results and discussion for Pb, As
and MeHg cytotoxicity experiments at chronic conditions were reported
by Karri et al. [65]. Upon the Pb exposure (10–100 μM) cell death was
significantly lower indicating that sensitivity of hippocampal cells to-
wards Pb is relatively low. Previous studies reported that As showed
cytotoxicity even at a micromolar concentration [78], and similar re-
sults were observed in HT-22 cells treated during 8 days. However,
MeHg (IC50= 0.6 μM) showed high potency in hippocampal cells (HT-
22) compared to Pb (IC50= 74.3 μM) and As (IC50= 0.8 μM) The ob-
tained MeHg results were consistent with previous studies in cerebellar
granule cells [79].
The obtained 8 days exposure MTT results were useful for further
mechanistic based assays such as apoptosis to know the chronic risk of
heavy metals on HT-22 cells. For that purpose, in a previous study, cells
were treated with a range of IC10 to IC30 concentrations (μM), and re-
sults were reported in Karri et al. [65]. This report confirmed that Pb
induced apoptosis process was low in HT-22 cells and agreement with
reported studies in (Fig. 1) [80]. The other two metals, As and MeHg,
showed significant effects even at low concentration of exposure [81,
82]. The results of the present study show that non-cytotoxic (IC10)
apoptosis mechanism also similar to cell viability in the potency of
metal. The selecting sub lethal (non-cytotoxic) concentration effects
suggest that for the three metals, the necrotic process was not initiated
under mild stress conditions. The MTT and apoptosis results indicate
that the toxicity potency of metals on hippocampal cell follows:
MeHg > As > Pb. Fig. 1 shows the apoptosis effect of Pb, As, and
MeHg onHT-22 cells after 8 days of exposure.
The findings from the MTT and apoptosis assay are interesting for
extending further to mechanistic experiments to find the underlying
molecular mechanisms. The high throughput label free omics analysis
could be helpful for understanding the complete overview of metal
induced stress in hippocampal cells and also validate the potency of
metals in HT-22 cells by analysing the protein expression. Here, we
selected the IC10/sub lethal concentration of Pb, As, and MeHg
(63.50 μM, 0.09 μM, and 0.42 μM) on HT-22 cells for omics studies.
3.1. Identification and quantification of proteins in HT-22 cells by using the
label free proteomic analysis
In order to identify new molecular pathways related to heavy metal
neurotoxicity, we have used a proteomics label-free quantitative ap-
proach with sub lethal (IC10) concentration in 8 days exposure. The
quantitative analysis was performed by Progenesis QI software as ex-
plained in the methods Section 2.7. In total 3140 proteins were quan-
tified from 27,088 peptide ions. From them, 2161 proteins were iden-
tified with a minimum of 2 peptides. Only the proteins with at least two
unique identified peptides were retained for further quantification
analysis. The unsupervised PCA was performed by using the normalized
proteins (≥2 unique peptide) that were present in all four (n=4) re-
plicates (Fig. 2A). The first principal component (PC1: 55.1%) describes
the largest variation in the dataset in which the samples spread the most
in the variable space. The second component (PC2: 13.2%) describes
the next largest variation and is orthogonal to the first component. The
third component describes the last largest variation (PC3: 6.3%).
Fig. 2A highlights clustering or pattern formations in a three-dimen-
sional space which provides a view of the similarities and dissimilarities
among the samples. For each individual metal, we extracted the pro-
teins showing significant changes in abundance when compared to
control cells (547, 1249 and 1156 proteins for Pb, As, and MeHg, re-
spectively). The resulting proteins of the three metal treatments were
compared in a venn diagram and shown in Fig. 2B. We found that 373
proteins commonly altered due to metal exposure. Interestingly, some
proteins were exclusively altered due to the exposure to each metal: 70
for Pb, 244 for As and 193 for MeHg. The experimental groups (control,
Pb, As and MeHg) were clustered based on the log standard abundance
of the unsupervised data with the ward's hierarchical clustering algo-
rithm. The clusters clearly separated according to the expression level
in each replicate as shown in Fig. 2C, and the spot maps of MeHg are
distinguished the most from the other spot maps. Differences were also
found between the controls, MeHg and As; Pb and Control were very
close in the cluster. We can notice the clear presence of a group of
proteins that are systematically upregulated (red) and down regulated
(green) in treatment Vs control. Volcano plot presents the protein
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expression response to Pb, As and MeHg, respectively (Fig. 3). The re-
plicates for the four study groups were averaged and ratios for each
metal treatment group to control were calculated. To ease visualization
of proteome alterations, ratios (or fold change; FC) were log(2) trans-
formed and plotted against −log(10) transformed ANOVA p-values
(Fig. 3, A–C) The presented pink dots (log(2)FC≥ 0.26 or≤0.26 and p-
value≤ .05) were considered as differentially expressed among each
metal treated and control comparison. A total of 547, 1249 and 1156
proteins were found to respond to Pb, As, and MeHg exposure respec-
tively. Among them, 347, 563, 632 proteins were significantly down
regulated, while 200, 686, 524 proteins were significantly upregulated
by Pb, As, and MeHg respectively. (See Fig. 3.)
3.2. Functional classification and enrichment analysis of protein data by
using GO – Elite
The functional interpretation and the pathway analysis of protein
expression are always challenging. The application of GO mapping and
pathway analysis with omics data to interpret the complex protein
expression profiles in the context of the molecular pathways [83]. This
study demonstrated that GO analysis by using GO–Elite method for the
functional interpretation of proteomics data. Our GO results contain
multiple files, in that over-representation analysis (ORA) pruned list are
most informative to understand the GO terms and proteins functional
relation (Supplementary file 1), which includes all summary term sta-
tistics and associated gene symbols. The ability to determine in which
GO terms differentially expressed proteins are overrepresented provides
an ideal model to gain an understanding of what GO classes are altered
after metal exposure. The pruned ORA list contains the GO terms; i) are
pruned to only include non-redundant information and ii) are sig-
nificantly altered based on changes in protein expression. The GO-Elite
results represent a global picture of biological processes, cellular com-
ponents, and molecular functions that are significantly altered at the
protein level after treatment of Pb, As and MeHg. Relationships be-
tween all regulated proteins and pruned terms can also be easily vi-
sualized as networks in cytoscape using the pruned sif file. We showed
global networks (Supplementary file 2) of the all pruned GO terms with
protein expression, which gives an overview of all the significantly
expressed proteins and which can be helpful to determine the heavy
metal's impact on HT-22 cells proteome. For instance, by observing the
GO terms and protein expression relation, we found that Pb metal im-
pact was very low while As and MeHg showed a greater impact on HT-
22 cells. A major challenge in the GO interpretation of omics data is the
functional interpretation and the linking of potentially altered proteins
to most relevant disease processes. However, from the overview of the
network file, it was difficult to relate the results to specific
Fig. 1. Representative dot plots showing the apoptosis effect of Pb, As, and MeHg to HT-22 cells upon 8 days of exposure at sub lethal experimental concentration
(n=3). C=Control, Pb= 63.50 μM, As=0.42 μM, MeHg=0.09 μM. Lower left (LL)/ E3=Live cells (Annexin V−/PI−), Lower right (LR)/ E4=Early apoptotic
cells (Annexin V+/PI−), Upper right (UR)/ E2= Late apoptotic (Annexin V+/PI+), Upper left (UL)/ E1=Necrotic cells (PI+).
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neurodegeneration processes.
Using the GO hierarchical classification system, we identified en-
riched processes within the collection of genes identified as sig-
nificantly altered by Pb, As, and MeHg exposure. Generally, ORA GO
terms are crucial to evaluate the significant GO processes with respect
to metal exposure. We observed that the obtained GO processes were
different for each metal exposure; although few of them were linked to
neurodegenerative diseases. Table 1 shows the different GO processes
for Pb. As and MeHg related to neurotoxicity in HT-22 cells. Regarding
Pb, proteins related to cysteine-type endopeptidase inhibitor activity
involved in the regulation of caspase related apoptosis are down-
regulated after Pb exposure, which indicates that the apoptosis process
was initiated by Pb in HT-22 cells. Some studies suggested the im-
portance of the JAK/STAT pathway for the survival of neurons [84].
This pathway has a pro-apoptotic nature in cerebellar granule neurons
[85]. Thus, the Pb exposure in HT-22 cells initiated the cell death
through apoptosis. In relation to As metal (Table 1), oxidative stress and
transition metal ion homeostasis GO processes are critically acclaimed
to metal toxicity. The regulation of oxidative stress is indicated by the
upregulation of antioxidant proteins, super oxide dismutase 1 (SOD1),
reduced glutathione (GSH) and the neuronal part GO term are indicated
by the amyloid precursor protein (APP), and parkin7 (PARK7) protein
expression that is critical for the neurodegenerative diseases. Most en-
riched and relevant to neurotoxicity in MeHg are the GO terms:
Fig. 2. A. Diagram presenting the principle component analysis (PCA) score plot (PC1, PC2, and PC3) of the unsupervised proteomic profiles of HT-22 cell B. Venn
diagram showing the overlap between significantly changed (p < .05) proteins in Pb, As, and MeHg metals. C. Heat map for hierarchical Euclidean clustering of
normalized protein expression of the experimental groups (control, Pb, As, and MeHg).
V. Karri et al. Journal of Proteomics 187 (2018) 106–125
111
pyruvate metabolic process, spliceosomal and transition metal ion
homeostasis. In AD, the process of β-amyloid (Aβ) misfolding and
plaque aggregation is greatly influenced by alterations in the transition
metal ion homeostasis [86]. Transition metal ions can influence the
APP metabolism [87]. We found in relation to the transition metal ion
homeostasis GO term, that APP protein expression is differently altered
by MeHg (down regulated) than by As (up regulated), which indicates
that heavy metal exposure controls the APP expression but in opposite
ways best supporting the underlying mechanism of the AD by As.
Our data demonstrate that GO analysis constitutes a powerful
unbiased approach to define the biological pathways altered in mice
HT-22 hippocampal cells in response to heavy metals exposure. The GO
processes shown in Table 1 for the three metals (Pb, As, and MeHg)
suggests that the involved proteins are sensitive indicators of metal
induced response in association with neurotoxicity. GO based omics
data analysis can provide profoundly important and novel information
in toxicity mechanism. However, we are currently facing the difficult
challenge of how quantitatively to interpret the differentially expressed
proteins. As presented in Table 1, the conventional GO process terms do
not provide any quantitative information about current data on metal-
Fig. 3. Volcano plot showing protein expression alteration after exposure to Pb (A), As (B), and MeHg (C) in HT-22 cells. The x-axis of the figure is the base 2
logarithm of the fold change over the control (n=4). The y-axis is negative base 10 logarithm of the p value for the per protein t-test (p≤ 0.05). The scattered points
represent proteins.
Table 1
Statistically significantly changed GO terms related to neurotoxicity in HT-22 cells for Pb, As and MeHg.
Ontology-ID Ontology Name Ontology Type Changed genes Measured Ontology Z Score
Pb
GO:0043028 Cysteine-type endopeptidase regulator activity involved in apoptotic process Molecular function 5 5 36 3.8
GO:0046426 Negative regulation of JAK-STAT cascade Biological process 3 3 12 2.9
GO:0045738 Negative regulation of DNA repair Biological process 3 4 8 2.2
GO:0034719 SMN-Sm protein complex Cellular component 6 11 17 2.2
GO:0097458 Neuron part Cellular component 46 141 927 2.0
As
GO:0032088 Negative regulation of NF-kappaB transcription factor activity Biological process 8 8 63 2.4
GO:1902882 Regulation of response to oxidative stress Biological process 7 7 27 2.2
GO:0007265 Ras protein signal transduction Biological process 19 24 99 2.1
GO:0055076 Transition metal ion homeostasis Biological process 12 14 99 2.0
GO:0097458 Neuron part Cellular component 95 141 927 2.3
MeHg
GO:0006090 Pyruvate metabolic process Biological process 18 21 55 2.9
GO:0050877 Neurological system process Biological process 31 43 1863 2.4
GO:0055076 Transition metal ion homeostasis Biological process 12 14 99 2.4
GO:0043028 Cysteine-type endopeptidase regulator activity involved in apoptotic process Molecular function 5 5 36 2.0
GO:0005687 U4 snRNP Cellular component 8 9 10 2.1
GO:0005683 U7 snRNP Cellular component 5 5 8 2.0
GO:0005689 U12-type spliceosome complex Cellular component 13 13 25 3.3
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induced neurotoxicity. Thus, we integrated the selected pruned GO
processes in a Cytoscape framework to evaluate functional relations
between the proteins, as illustrated in Figs. 4, 5, and 6 for Pb, As, and
MeHg, respectively. This analysis can useful to visualize how each
protein with its significant change in expression connects to the neu-
rotoxicity GO terms. In particular, we were able to show the effects of
the metal on the protein expression profiles in HT-22 cells as presented
by Pb, As, and MeHg networks. We quantitatively assessed the absolute
magnitude of change in expression levels associated with significant
proteins within enriched GO terms at IC10. It was observed that MeHg
caused the most prominent changes in protein abundance than other
two metals. So that, here we will mainly focus on the MeHg induced
damage in HT-22 cells which is critical to evaluate the relationship
between the protein expression and AD and PD; the other two metals
(Pb and As) are discussed in a comparative manner.
3.3. Pathway analysis: visualization of pathways relevant to heavy metal
(Pb, As, and MeHg) induced neurodegeneration in HT-22 cells
Pathway analysis was used to further explore the complex interac-
tions in a biological system and to discover the relations between dif-
ferentially expressed proteins and their relevance to (AD, and PD. In
general, toxicological studies related to Pb, As and MeHg have proposed
few common predominant mechanisms that relate to neurotoxicity. The
obtained results suggest that for AD and PD the pathways: mRNA reg-
ulation/splicing, ubiquitin proteasome system (UPS), oxidative stress,
electron transport chain (ETC) dysfunction, are the most affected by
MeHg and As exposure; however, the Pb metal impact was low. Notable
proteins found in the ETC dysfunction, oxidative stress, mRNA splicing
process, and UPS degradation also relate to AD and PD. Table 2 shows
the pathways that significantly changed proteins relevant to neurode-
generation process in HT-22 cells.
3.3.1. Effect of Pb, As and MeHg on mitochondrial electron transport chain
(ETC) dysfunction
The mitochondrion is a critical regulator of neuronal cell death
[88]; a failure of one or more of the mitochondrial ETC enzymes gen-
erates reactive oxygen species (ROS), and leads to neuronal death [89].
It is a tempting to speculate that the modification of ETC proteins leads
to depletion of ATP production in HT-22 cells. We found protein dys-
regulation in all complexes of the ETC, suggesting a broad toxicity of
metals on ETC of HT-22 cells. As shown in Fig. 7, MeHg treatment
(IC10) induced significant alteration of proteins in complex I–V. The
pattern of protein expression alerted by As in the ETC pathway was
similar to that of MeHg. In the present study, cytochrome c oxidase
(COX)/complex-IV and F1 F0-ATPase activities seemed highly dysre-
gulated by the MeHg and As exposure. MeHg is known to directly
disrupt the mitochondrial activity by generating the uncontrolled re-
lease of Ca+2 from the mitochondria and inhibiting phosphorylation,
Yee et al. reported that MeHg inhibits the mitochondrial ETC in a
cultured brain cell line [90]. The findings of mitochondrial ETC damage
due to MeHg and As metal exposure is an agreement with previously
Fig. 4. Interaction of differentially expressed proteins and selected GO classes after Pb exposure. The network is based on the selection of the pruned GO terms and
was visualized in Cytoscape. The network includes over-represented GO terms and associated differentially expressed proteins. The changes in protein expression are
coloured as a gradient going from blue (=downregulated) to red (=upregulated) and GO terms are coloured in green. (For interpretation of the references to colour
in this figure legend, the reader is referred to the web version of this article.)
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reported results in AD patients from post mortem hippocampus [91].
The reduced activity of F1 F0-ATPase (complex-V) could compromise
the ATP production and induce the generation of ROS leading to neu-
ronal cell death [92]. The ETC dysfunction after metal exposure in HT-
22 cells seems to correlate with the previously reported findings of
Valla et al. [93]. Reported studies for deficiency in the activity of the
mitochondrial ETC NADH dehydrogenase (complex I) in PD [94],
which is in an agreement with ETC dysfunction in the HT-22 cells. Our
findings confirm that the metals disrupt the ETC function in HT-22 cell,
and that may relate to energy deficiency, a characteristic feature of both
AD and PD [95]. The observed ETC changes raise further questions
[96]. Not only direct effects of ETC function, but also other proteins
Fig. 5. Interaction of differentially expressed proteins and selected GO classes after As exposure. The network is based on the selection of the pruned GO terms and
was visualized in Cytoscape. The network includes over-represented GO terms and associated differentially expressed proteins. The changes in protein expression are
coloured as a gradient going from blue (=downregulated) to red (=upregulated) and GO terms are coloured in green. (For interpretation of the references to colour
in this figure legend, the reader is referred to the web version of this article.)
Fig. 6. Interaction of differentially expressed proteins and selected GO classes after MeHg exposure. The network is based on the selection of the pruned GO terms
and was visualized in Cytoscape. The network includes over-represented GO terms and associated differentially expressed proteins. The changes in protein expression
are coloured as a gradient going from blue (=downregulated) to red (=upregulated) and GO terms are coloured in green. (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this article.)
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(next section) involved in AD and PD can also impact various mi-
tochondrial functions [97]. There is no evidence that any of the Pb, As,
and MeHg metals directly produce only mitochondria based neurode-
generation processes [98], although other pathways present the direct
or indirect relation to ETC dysfunction.
3.3.2. Effect of Pb, As, and MeHg on ROS mediated oxidative stress
The present results (Fig. 8) indicate that generation of ROS can
relate to ETC damage and monoamine oxidase A (MAO-A) elevation in
the HT-22 cells. The presented oxidative stress pathway gives an
adaptive response in HT-22 cells to maintain redox homeostasis to fight
against the heavy metal induced stress. We found that MAO-A protein
expression in HT-22 cells in the all three metals, MAO-A participates in
the degradation of amines and thereby controls neurotransmitter levels
in the brain [99]. In the present study, MAO-A expression changed in a
contradictive manner among three metals; As (downregulation) while
Pb and MeHg (upregulation), which indicates that Pb and MeHg might
be enhancing the monoamine metabolism in HT-22 cells. The obtained
MAO-A expression in MeHg is in disagreement with reported MeHg
effect in vitro embryo culture experiments [100]. As metal also showed
that MAO-A expression was opposite to reported studies, instead of
upregulation the effect was downregulated [101]. Pb altered mitogen-
activated protein kinase (MAPK) functions leading to the production of
ROS causing neuronal cell death [102]. The relationship between AD
and increased enzyme activity for MAO has been known for a long time;
MAO-A protein activity levels are elevated in the AD [103]. The MAO-A
elevated AD brain is subjected to increased oxidative stress resulting
from ROS [104]. Thus, the MAO-A activity could be altered by Pb, As
and MeHg indirectly through the changes in -SH groups [105]. The
results support that MAO-A may be a useful biomarker for Pb, As and
MeHg on the hippocampal cells. The MAPKs plays an important role in
the cascades of cellular responses evoked by extracellular stimuli such
as the heavy metal exposure [106]. Our results demonstrated a sig-
nificant alteration in MAPKs mediated oxidative stress response
(Fig. 8). The induction of antioxidant and phase II detoxifying enzymes
acts as an important defensive mechanism against heavy metal induced
stress in HT-22 cells.
Table 2
Six pathways showed significantly changed proteins relevant to neurodegen-
eration process in HT-22 cells.
Pb As MeHg
Pathway Measured (n) Positive (r) Positive (r) Positive (r)
Electron transport
chain
31 12 17 21
mRNA processing 191 51 104 115
Proteasome
degradation
40 9 18 7
Alzheimer's disease
pathway
17 3 9 20
Parkinson's disease
pathway
10 1 7 6
Oxidative stress 12 4 9 7
*Measured (n) is the number of gene products in the pathways that are mea-
sured in the Pb, As and MeHg data sets; positive (r) is the number of differ-
entially expressed proteins in the presented pathway for each metal.
Fig. 7. Changes in protein expression in electron transport chain (ETC) pathway in response to Pb, As and MeHg in HT-22 cells. The pathway changes in protein
expression are visualized as log2 fold change comparing treatment with control expression. In addition, the significance level of these changes is indicated by p
values. Red indicates a higher level of expression in the treatment. The changes in protein expression are coloured as a gradient going from blue (=downregulated)
over white (unchanged) to red (=upregulated) and p values < .05 are coloured in green and p values≥ 0.05 are in white. Grey indicates that the selection criteria
were not met, but the protein is measured. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Pb, As and MeHg in HT-22 cell line induced significant effects in
MAPKs mediated oxidative stress response such as anti-oxidant pro-
teins, hemeoxygenase1 (HMOX1), NAD (P)-H dehydrogenasequinone1
(NQO1), glutathione disulfide reductase (GSR), superoxidedismutase1
(SOD1), superoxide dismutase2 (SOD2), catalase (CAT), thioredoxin
reductase1(TXNRD1), glutamate cysteine ligase catalytic (GCLC) sub-
unit, and metallothionein-1(MT1). All proteins are involved in the ac-
tivation of antioxidant activity in HT-22 cells supporting the heavy
metals stress. The increase in the antioxidant proteins is a compensating
mechanism for the decrease in the ATP producing due to ETC dys-
function in HT-22 cells. In contrast to Pb metal; MeHg and As sig-
nificantly alter some forms of antioxidant and detoxification enzyme
which indicates clearly the higher potency of As and MeHg. Also, MeHg
and As induce significant upregulation of GSR and SOD2; although CAT
protein expression was observed similarly in both Pb and As. The ob-
tained results show that expression/fold change of antioxidant proteins
depends on the potency of each metal; MeHg considerably alters the
normal pattern of antioxidant elements expression than other two
metals. Biochemically MeHg has high affinity to sulphur (-SH) con-
taining molecules, mainly targeting cysteine containing proteins [107].
Oxidative stress has been implicated in the wide variety of biolo-
gical reactions such as cell death in the central nervous system [108].
ROS induced oxidative stress has been demonstrated to activate mem-
bers of the MAPKs via phosphorylation [109] and it is also implicated in
neurodegenerative disorders [110]. Thus, heavy metal induced ROS can
elicit oxidative stress that can be the main cause to trigger various
neurodegenerative diseases [111, 112]. ROS is also well known to cause
mitochondrial dysfunction and induces cell death in neurons [113].
Previous studies indicated that MeHg disrupts cellular redox home-
ostasis and the mitochondrial ETC, via excessive generation of ROS
[114, 115]. The disruption of ETC function can also correlate with
various proteins in oxidative stress such as MT1, SOD, GSH, CAT,
HMOX1, and NQ01. Oxidative stress has been shown not only to initiate
the onset of disease but also exacerbates specific diseases like AD and
PD [116].
3.3.3. Effect of Pb, As, and MeHg on UPS pathway
In addition to selective damage of ETC and oxidative stress in HT-22
cells, UPS may also contribute to neurodegeneration processes [117].
The UPS is essential for the non-lysosomal degradation and clearance of
short-lived, misfolded, mutant, and damaged proteins in eukaryotic
cells. Structural and functional deficits in the 26/20S proteasome can
lead to AD, and PD [118, 119]. The UPS is a highly conserved cellular
pathway that plays an important role in the selective degradation of
cellular proteins that are essential for the regulation of a variety of vital
cellular functions [120]. Disruption of this system can have significant
downstream effects on critical cellular functions. In Fig. 9, Pb, As and
MeHg metal showed nonspecific proteasome alterations of proteasome
subunits of the 20S catalytic core and the 26S (PA700) regulatory
complex. The pattern of expression in UPS is metal specific with re-
levance for neurodegeneration. For instance, ubiquitin carboxyl-term-
inal esterase L3 (UCHL3) expressions were upregulated in the As ex-
posure, although the other two metals (Pb and MeHg) had no effect.
UCHL3 is a deubiquitinating enzyme that is involved in the pathogen-
esis of both AD and PD [121]. Recently, an increased amount of oxi-
datively modified UCHL3 in the brains of the AD and PD patients,
compared to normal brains was reported [122]. Ubiquitin-like modifier
activating enzyme 1 (UBA1) is a key regulator of protein homeostasis
and expression of UBA1 is essential for cell survival. Our results suggest
that Pb, As, and MeHg metal upregulates the UBA1 expression in HT-22
cells. Moreover, UBA1 can be sequestered into PD disease associated
protein aggregates [123]. Additionally, for MeHg, we observed down-
regulation of the NEDD4 (ubiquitin E3 ligase/ parkin), which indicates
that MeHg has a significant impact on the number of protein targets in
HT-22 cells. In contrast, Pb and As metal upregulates the NEDD4 pro-
tein in UPS pathway. NEDD4 plays a crucial role in ubiquitination; this
Fig. 8. Changes in protein expression in oxidative stress pathway in response to Pb, As and MeHg in HT-22 cells. In the pathway, changes in protein expression are
visualized as log2 fold change comparing treatment with control expression. In addition, the significance level of these changes is indicated by p values. Red indicates
a higher level of expression in the treatment. The changes in protein expression are coloured as a gradient going from blue (=downregulated) over white (un-
changed) to red (=upregulated) and p values < .05 are coloured in green and p values≥ .05 are in white. Grey indicates that the selection criteria were not met, but
the protein is measured. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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enzyme enhances the cell survivability by decreasing the apoptosis
process in HT-22 cells. We found that the expression was down-
regulated during MeHg exposure, which indicates the UPS dysfunction.
The accumulation of parkin specific substrates, as a consequence of the
loss of NEDD4 activity, might underlie the damage of dopaminergic
neurons [124]. Other proteins in the PD pathway (Fig. 12) such as
SEPT-5 and ATAXIN-2 have interaction/connection with NEDD4 func-
tion and also play a key role in PD (both proteins are upregulated in PD
pathway). This upregulation process can decrease the NEDD4 activity
of the proteasome after MeHg exposure in the hippocampal cell line.
We found the bunch of proteins dysregulation in the proteasome 26
subunit, in which the PSMC5 protein has a critical role in the de-
gradation of unfolded proteins. The expression was downregulated in
HT-22 cells after MeHg exposure but upregulated with Pb and As.
Overall, the UPS pathway disruption shows that most of the protein
expression was similar for all three metals (except NEDD4 expression).
The findings with the UPS pathway clearly show that the potency and
molecular mechanism related to PD is different for the three metals. For
instance, comparisons of the protein expression level between the three
metals by omics data revealed the common targets in the UPS of the HT-
22 cells but the way of influence/interaction on the protein is different.
Pb, As and MeHg treatment in HT-22 cells induced significant alteration
of UPS pathway proteins, including the significant alterations in the
proteasome 26S regulatory and 20S catalytic core unit and in the ubi-
quitin enzyme system (UBA1, NEDD4, and UCHL3), which are highly
essential for protein quality control during normal cell function. MeHg
effect on E3 ligase enzyme was reported in human cell lines [125, 126].
This report suggests that MeHg induces the cellular accumulation of
certain proteins that cause neurodegeneration. Mouse neuronal HT4
cells treated with toxic metals have been reported to induce accumu-
lation of ubiquitination with a decrease in cell viability [127]. This
report also shows the critical role of the UPS in the removal of proteins
that are oxidatively modified and suggests that accumulation of ubi-
quitinated proteins in the HT- 22 cells contributes to an overall toxicity.
In Fig. 9, the comparison of alterations in protein expression between
the metals Pb, As, and MeHg revealed both common and unique targets
in the UPS. Although the involvement of the UPS pathway might be
different among various cell types, results from this omics data strongly
support that the disruption of the UPS function is involved in metal-
induced neurotoxic effects and denotes the potential protein targets in
this pathway. Several studies have identified the critical role of the UPS
in the metal induced toxicity [128–132]. It is clear that alterations in
UPS function are key factors in the final development of AD and PD;
more research is needed to elucidate the exact mechanisms and order of
events concerning the role of the UPS in neurodegenerative diseases.
3.3.4. Effect of Pb, As, and MeHg on mRNA splicing pathway
Alternative splicing is one of the most important mechanisms to
generate a large number of mRNA and protein isoforms from the low
number of human genes [133]. It is a widespread gene regulatory
Fig. 9. Changes in UPS in response to Pb, As, and MeHg in HT-22 cells. In the pathway, changes in protein expression are visualized as log2 fold change comparing
treatment with control expression. In addition, the significance level of these changes is indicated by p values. Red indicates a higher level of expression in the
treatment. The changes in protein expression are coloured as a gradient going from blue (=downregulated) over white (unchanged) to red (=upregulated) and p
values < .05 are coloured in green and p values≥ .05 are in white. Grey indicates that the selection criteria were not met, but the protein is measured. (For
interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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process by which exons of primary transcripts (pre-mRNAs) are spliced
into different arrangements to produce structurally distinct mRNA
variants [134]. This mechanism of gene product plays a critical role in
cell function [135]. It is estimated that> 75% of genes in the human
genome are alternatively spliced in the central nervous system [136].
Dysregulation of alternative splicing has been linked to the number of
human diseases including neurodegenerative diseases [137]. The spli-
ceosome is a complex of five small nuclear ribonucleoprotein particles
(snRNP: U1, U2, U4, U5, and U6) and numerous protein factors. In
Fig. 10showed snRNP bind to the pre-mRNA in a sequential manner,
following the binding of U4/U6, U5 tri-snRNP, the spliceosome un-
dergoes extensive structural remodelling leading to the release of U1,
U2 subunits, and activation of the spliceosome [138–140]. In Fig. 10,
we addressed the impact of Pb, As and MeHg on splicing and the re-
lationship between neurological disease and the regulation of alter-
native splicing. Alternative splicing is particularly applicable in the
present results, because of the great number of protein changes ob-
served in the mRNA processing. In addition, we identified several
components of the U1 small nuclear ribonucleoprotein (U1 snRNP) al-
terations in HT-22 cells. Our findings demonstrated a unique damage of
splicing in HT-22 cells. The functional consequences of these observa-
tions can reflect the neurodegeneration processes [141]. We found that
U1snrp70K (U1 small nuclear ribonucleoprotein 70 kDa) protein ex-
pression was upregulated in As metal exposure; the other two metals
have no significant effect. This protein has a critical role in the APP
protein metabolism [142]. The alterations of U1snRNP are in
agreement with discovered U1 snRNP defect in the AD brain [143]. We
found U2 snRNP protein dysregulation with all three metal exposures. A
reported study denoted that the mutation in U2 snRNP genes causes
defects in pre-mRNA splicing, leading to neurodegeneration [144]. Our
results showed a high number of altered proteins in the U2snRNP unit,
and U2 snRNP plays an essential role in the formation of the catalyti-
cally active spliceosome by base pairing with both the intron branch
point and the U6 snRNA [145]. The last functional tri-protein (U4, U5,
and U6) system function was downregulated in HT-22 cells, which in-
dicates the mechanism of splicing is completely altered by heavy metal
exposure. Additionally, we found abnormal changes in the serine/ar-
ginine rich proteins (SR) Sfrs1, Sfrs2, Sfrs3, Sfr5, and Sfr6; SR proteins
are one family of splicing factors involved in the alternative splicing of
tau protein. The changes in SR proteins probably influence the reg-
ulation of the alternative splicing of the tau gene [146]. In that way,
heavy metal induced protein alterations in SR proteins may contribute
to the AD by controlling the tau protein expression [147]. The present
findings enable mechanistic insight into how aberrant changes in al-
ternative transcript expression occur in the AD and highlight the sus-
ceptibility network of splice-regulatory proteins which can potentially
link the number of susceptibility pathways [148]. Taken together, these
observations imply that alterations in snRNP accumulation and conse-
quently pre-mRNA splicing can contribute to the etiology of multiple
neurodegenerative disorders [149]. Alternative splicing is tissue spe-
cific and especially important for brain tissue, thus the metal disrupted
spliceosome has a big impact in HT-22 cells.
Fig. 10. Changes in mRNA splicing in response to Pb, As and MeHg in HT-22 cells. In the pathway, changes in protein expression are visualized as log2 fold change
comparing treatment with control expression. In addition, the significance level of these changes is indicated with p values. Red indicates a higher level of expression
in the treatment. The changes in protein expression are coloured as a gradient going from blue (=downregulated) over white (unchanged) to red (=upregulated) and
p values < .05 are coloured in green and p values≥ .05 are white. Grey indicates that the selection criteria were not met, but the protein is measured. (For
interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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3.3.5. Effect of Pb, As, and MeHg on Alzheimer disease (AD) pathway
The AD is a complex, irreversible neurodegenerative disease char-
acterized by the impairment of cognitive function. In the present study,
it is conceivable that the observed alterations in the AD specific pro-
teome of HT-22 cells could cause the alterations in the APP. Our find-
ings in Pb and As comply with a previous study that showed an in-
creased hippocampal and cortical APP protein processing causing
cognitive dysfunction [150]. Also, we observed significant changes in
CAPN1 and CAPN2 (calcium-dependent, and non-lysosomal cysteine
proteases). It's known that calpains is implicated in neuronal cell death
and long term potentiation (LTP) in the hippocampus [151]. In our
study, CAPN2 expression was upregulated by MeHg and As, which
clearly suggests the AD relationship with heavy metals exposure. Pre-
viously it was reported that CAPN2 can improve survival of hippo-
campal neurons [152]. The other protein, low-density lipoprotein re-
ceptor-related protein1 (LRP1 protein) was upregulated with As and
MeHg. LRP1 is implicated in the effective clearance of Aβ from the
brain. It indicates that HT-22 cells compensate for the Aβ clearance
through the LRP1 protein [153]. NEDD8-activating enzyme E1 reg-
ulatory subunit (NAE1/APPBP1) expression was found in As exposure,
that binds to the APP protein carboxyl-terminal domain [154], results
in neuronal cell death [155]. The AD is also characterized by the ac-
tivation of apoptotic pathways. However, the hypothesis that apoptosis
plays a role in AD neurodegeneration remains controversial. Caspase
activation can occur independent of cell death and may be neuro pro-
tective [156, 157]. CASP8 expression was found altered after the As
exposure, which leads to the receptor mediated apoptotic pathway to
activate CASP3 within neurons of the AD brain [158]. We found that
expression of CASP3 that indicates that HT-22 cell death may be in-
itiated in an apoptosis-dependent manner. Generally, Pb, As and MeHg
predominantly induce CASP3 like protease activity in brain cell culture
[159–161] The activation of CASP3 is known to an enhanced genera-
tion of alternative presenilin cleavage fragments in the AD, but exactly
not clear [162]. Here, we found CASP3 expression in relation to tau
protein in the AD pathway (Fig. 11) which is entirely different from the
metal induced apoptosis assumption [163] and thus, may contribute to
cellular demise in a different manner [164].We also found that heavy
metals induced AD in relation to other pathways. For instance, APP
dysregulation can be possibly due to mitochondrial ETC, oxidative
stress, transition metal ion homeostasis, and mRNA splicing. These AD
related a protein has been previously discussed in other pathways
Sections 3.3.1, 2, 3, and 4. For instance, the impairment of mitochon-
drial function has been well known in AD patients [165]. ETC dys-
function (Fig. 7) and reduced ATP have an immense impact on brain
metabolism [166]. PCR analysis revealed that the downregulation of
mitochondrial proteins of complex- I in AD brain, suggesting energy
deficits in AD brains [167]. In addition, several in vitro studies of APP
and mitochondrial function have reported that APP expression affects
the mitochondrial DNA and proteins, leading to impairments of the ETC
[168, 169]. With As and MeHg we found that the transition metal ion
homeostasis GO term represents a process necessary for the correct
functioning of antioxidant systems in the cell [170]. Biometals such as
iron (Fe), zinc (Zn) and copper (Cu) play an important role in several
neurodegenerative disorders [171]. As and MeHg are such toxic metal
Fig. 11. Changes in AD in response to Pb, As, and MeHg in HT-22 cells. In addition, the significance level of these changes is indicated with p values. Red indicates a
higher level of expression in the treatment. The changes in protein expression are coloured as a gradient going from blue (=downregulated) over white (unchanged)
to red (=upregulated) and p values < .05 are coloured in green and p values≥ .05 are in white. Grey indicates that the selection criteria were not met, but the
protein is measured. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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which influences the essential metal transportation that relates to Aβ
aggregation [172], and also Fe, Pb and Mn and their mixture may raise
the risk of PD [173]. The expression of APP in the brain suggests these
metals could have a direct or indirect role in neuronal metal home-
ostasis [174], for instance, Cu deficiency downregulates APP tran-
scription [175]. The association between APP and transition metals
such as Fe and Cu lead to the generation of hydrogen peroxide, ex-
acerbating the oxidative damage [176]. Few studies have investigated
the link between alternative splicing dysregulation, and AD progression
[177]. Evidence of abnormal mitochondrial ETC gene expressions from
our studies suggests that APP in AD pathway may affect mitochondrial
function, which generates ROS, ultimately leading to oxidative damage
[178, 179]. However, the precise mechanistic link between mitochon-
drial oxidative damage and abnormal APP processing by heavy metals
has not been elucidated. Further studies are needed to support the
mechanistic link between abnormal mitochondrial gene expression and
oxidative damage in AD progression by heavy metal exposure.
3.3.6. Effect of Pb, As, and MeHg on Parkinson disease (PD) pathway
PD is the second most prevalent progressive neurodegenerative
disease [180]. In this study, several proteins are showed differential
expression relates to PD. The pathway analysis of metal exposure on
HT-22 cells proved particularly valuable for PD because we found
significantly changed proteins belonging to the PD pathway. These PD
related proteins also appeared in other pathways, for instance, ETC
dysfunction, oxidative stress, UPS pathway, and mRNA splicing. A de-
tailed study of the PD pathway (Fig. 12) made it plausible that the
observed alterations at the protein level in HT-22 cells could be related
to PD such as PARK7, CYCS (cytochrome c, somatic), and CASP3 as key
regulators of proteins for cell homeostasis. We found that the expression
was upregulated by the three metals treatment, which clearly shows
that HT-22 cells are under stress. Also, other proteins such as UBE2L3
(Ubiquitin-conjugating enzyme E2 L3), SEPT-5 (septin), and ATAXIN-2
protein expression was altered in the PD pathway. SEPT-5 protein in-
teracts with NEED4 in PD. Indeed, we found that As and MeHg altered
UBA1 and NEDD4 (Fig. 9) expression, respectively, in the UPS pathway.
This SEPT-5 upregulation in MeHg can decrease the activity of NEDD4
resulting in lower ubiquitin proteasome degradation in the hippo-
campal cell line. In As exposure, the interaction mechanism between
NEDD4 and SEPT-5 proteins is entirely opposite to MeHg. NEDD4 has
been intimately linked to mitochondrial quality control, which evi-
dence suggests that PARK7, ATP13A2, and FBXO7 may also be involved
[181]. In our data, the expression of CYCS and CASP3 were upregulated
by the three metals. The loss of mitochondrial membrane potential and
translocation of CYCS into the cytosol lead to cell death [182]. In
parallel, PARK7 protein is upregulated, which will protect the cells
Fig. 12. Changes in Parkinson's disease in response to Pb, As, and MeHg in HT-22 cells. In addition, the significance level of these changes is indicated by p values.
Red indicates a higher level of expression in the treatment. The changes in protein expression are coloured as a gradient going from blue (=downregulated) over
white (unchanged) to red (=upregulated) and p values < .05 are coloured in green and p values≥ .05. Grey indicates that the selection criteria were not met, but
the protein is measured. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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from the apoptosis stress. PARK7 has been thought as an endogenous
redox sensor, which prevents the cell from stress-induced apoptosis
[183]. Thus, PARK7 is believed to be protective against oxidative stress
in PD brains [184]. PARK7 expression in HT-22 cells was suggested to
be related to the oxidative stress and dopaminergic neurodegeneration
[185] (Fig. 12).
The expression pattern of PARK7, CYCS and CASP3 supports that
the three metals affect mitochondrial function which is relevant to PD,
with the potency in order of Pb < As<MeHg. The pattern of ex-
pression of interlinked proteins in the PD and UPS pathways of the
MeHg and As metal exposures is somehow different. As metal sig-
nificantly upregulates the UBA1 and NEDD4 and downregulates SEPT-5
in HT-22 cells. Thus, UBA1 might be sequestered into disease associated
protein aggregates, also shown for lewy bodies in As exposure models of
PD [186]. For MeHg, we observed downregulation of NEDD4 (Fig. 9).
NEED4 has a role of the E3 ubiquitin ligase, participating in the pro-
teasome degradation system [187], of which the loss of function allows
the formation of these toxic aggregates in neurons. Target proteins of
MeHg treatment in HT-22 cells related to PD suggest a direct relation to
the UPS pathway. The downregulated NEDD4 proteins during MeHg
exposure is critical for inducing the indirect way of PD by affecting the
UPS function. The results of our proteomics analysis using hippocampal
HT-22 cells strongly suggest that the disruption of UPS function is an
important mechanism in metal induced neurotoxicity. Moreover, ad-
ditional evidence supports not only the important role of NEED4 as an
E3 ligase in PD but also this protein can lead to mitochondrial im-
pairment in the brain [188]. Our findings comply with the previous
report that NEDD4 protein expression can correlate to alternative
splicing defects, which is one of the reasons for PD [189].
The heavy metal induced PD is likely to be multifactorial; ETC
dysfunction, oxidative stress, and the impairment of UPS dependent
protein degradation have been identified as the main processes asso-
ciated with PD [190]. Our findings confirm that the metals disrupt the
ETC pathway in HT-22 cell and influence the PARK7, and NEDD4 ex-
pression [191]. We found that NEED4 expression was downregulated in
the MeHg exposure, which correlates with previously reported alter-
native splicing defects and PD [188](Tan et al., 2005). We also found
that the heavy metal induces oxidative stress and mitochondrial
dysfunction, which is directly or indirectly related to PD [192, 193].
Our results also support that As and MeHg treatments highly influence
the ETC, oxidative stress and UPS pathway which are relevant to the PD
pathway [194] (Fig. 13). Finally, PD is associated with a number of
biochemical abnormalities, in which the UPS and ETC plays a major
role. Indeed, inhibition of proteasomal function has been shown to
cause oxidative stress and mitochondrial dysfunction [195–199].
4. Conclusions and future directions
Chronic exposure to the toxic metals Pb, As, and MeHg has been
associated with the neurological degeneration. Nowadays, knowledge
of neurodegenerative diseases has advanced rapidly, and the field holds
great promise for improving the understanding and the eventual
treatment of disease. To date, this study is the first report of com-
parative heavy metals neurotoxicity assessment by using the omics and
systems biology tools. For the proteomics analyses, we selected sub
lethal toxic concentrations (IC10) of each metal on HT-22 cells on 8 days
exposure as a chronic. Omics based analysis concentration of testing
chemical has had a critical role for the success of this study. If the
chemical concentration is too high, the secondary effects could mask
the primary response. Thus, preliminary cytotoxicity, genotoxicity, and
apoptosis observations were used to select the defined concentration.
The functional interpretation of protein expressions is always challen-
ging. In this study, we employed both GO analysis and PathVisio ap-
proaches for systems biology analysis. Using these integrated tools, we
identified significant protein expression changes across treatments re-
lated to AD, PD pathways. Our results confirmed that GO and PathVisio
analysis is a powerful approach to generate an unbiased view of the
functional protein alterations by heavy metals. The application of such
quantitative interpretation of toxicogenomics data is likely to become
increasingly useful for evaluating the mechanistic similarity of novel
chemicals.
The current study describes toxicity profile in the form of protein
expression that is observed in response to toxic metals exposure. These
changes may provide further insight into mechanisms underlying the
development of metal-induced diseases. These proteins are also candi-
date biomarkers of metal exposure that could potentially be used
Fig. 13. Proposed potential underlying neurotoxicity mechanisms of Pb, As, and MeHg. Metals exposure cause proteomic alterations in hippocampal cells including
the proteins related to energy metabolism, oxidative stress, UPS, PD, AD (+ sign enhance the damage, − sign ATP depletion).
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diagnostically in molecular and epidemiologic studies. The findings
from our results have greatly expanded understanding of the role of
mitochondria in the pathogenesis of neurodegenerative diseases.
Mitochondrial ETC dysfunction, oxidative stress, UPS dysfunction and
mRNA splicing changes occur early in all major neurodegenerative
diseases, and there is strong evidence that this dysfunction has a causal
role in disease pathogenesis. Greater improvement of these pathways
will be required to understand fully the pathogenesis of neurodegen-
erative disorders. Both PathVisio and GO interpretation integrated
systems biology supports that the potency of heavy metals is as follow:
Pb < As < MeHg. In summary, the comparison of protein expression
among Pb, As and MeHg revealed both common and unique protein
targets that relate to neurodegenerative diseases. The involvement of
mRNA splicing and the UPS pathway are new findings. The results of
our proteomics analysis strongly suggest that the disruption of mRNA
splicing, UPS, ETC and oxidative stress plays a crucial role in metal
induced neurodegenerative diseases. Obviously, the utility of tox-
icogenomics has promising advantages on assistance and refinement of
the risk assessment process, particularly the dose response analysis.
Future work will focus on using these data to explore basic neuro-
degeneration mechanisms of metals and the toxicity of their mixtures to
generate new hypotheses. Although relatively less toxic doses (IC10)
were used in the current analysis, a wide dose range study including an
environment relevant dose is needed to further examine the association
of metal exposure and its neurodegeneration. These heavy metal re-
sponse patterns may shed new light on the mechanisms of toxic metal
induced neurodegeneration, and may also be useful for the develop-
ment of molecular biomarkers of exposure in mechanistic studies and
risk assessment.
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